Eric Hyllengren | Vice President of Investor Relations and Finance |
Dr. Pascal Touchon | President and Chief Executive Officer |
Dr. Jakob Dupont | Executive Vice President and Global Head of Research and Development |
Utpal Koppikar | Chief Financial Officer |
Dr. AJ Joshi | Chief Medical Officer |
Salim Syed | Mizuho Group |
John Newman | Canaccord |
Phil Nadeau | Cowen and Company |
Kallie Briza | Stifel |
Jessica Hui | Evercore |
Good afternoon, everyone. Thank you for standing by, and welcome to the Atara Biotherapeutics Third Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] Please be advised that today's call is being recorded.